Trevi Therapeutics Inc (TRVI) financials · $2.32B cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Trevi Therapeutics Inc (TRVI) $2.32B cap.
| Line | FY2025 | FY2024 | Pro (2 older periods with Lician Pro) |
|---|---|---|---|
| Operating Income | −$49.33M | −$51.52M | |
| Net Income | −$42.76M | −$47.91M | |
| EPS (Diluted) | −$0.32 | −$0.47 | |
| Unlock 5 years of statements: Lician Pro $149/yr | |||
| Line | FY2025 | FY2024 | Pro (3 older periods with Lician Pro) |
|---|---|---|---|
| Total Assets | $193.44M | $110.90M | |
| Current Assets | $191.66M | $109.43M | |
| Cash & Equivalents | $18.91M | $34.10M | |
| PP&E | $178.00K | $157.00K | |
| Total Liabilities | $10.20M | $11.26M | |
| Current Liabilities | $9.75M | $10.51M | |
| Shareholders' Equity | $183.24M | $99.64M | |
| Retained Earnings | −$329.80M | −$287.05M |
| Line | FY2025 | FY2024 | Pro (3 older periods with Lician Pro) |
|---|---|---|---|
| Operating Cash Flow | −$42.09M | −$38.26M | |
| CapEx | $12.00K | $35.00K | |
| Investing Cash Flow | −$94.11M | −$21.53M | |
| Financing Cash Flow | $121.01M | $61.48M | |
| Net Change in Cash | −$15.18M | $1.70M | |
| Free Cash Flow | −$42.10M | −$38.29M |
Source: Company filings with the SEC (EDGAR) · Latest period FY2025
FAQ
What is TRVI P/E and revenue?
Trevi Therapeutics Inc (TRVI) $2.32B cap.
What is TRVI revenue?
TRVI income-statement cache has no revenue figure yet.
Is TRVI profitable?
Trevi Therapeutics Inc last cached net income is -$42.8M (FY2025).
What are TRVI total assets?
Trevi Therapeutics Inc last cached total assets are $193.4M (FY2025).
What is TRVI free cash flow?
Trevi Therapeutics Inc last cached free cash flow is -$42.1M (FY2025).
Not investment advice. Figures as reported in company filings, not a live feed.